AGI Therapeutics agitherapeutics.com


Public lists: Pharma Startups (6570)

AGI Therapeutics, based in Ireland, was established in 2003 by a group of experienced senior industry executives who have a successful track record in developing pharmaceutical products for all major global markets over the past 20 years. AGI Therapeutics is focused on developing new improved drug therapies for gastrointestinal diseases and disorders. The company applies its KME development model to identify existing drugs or "˜known molecular entities' with established safety profiles which ca...Show all

AGI Therapeutics, based in Ireland, was established in 2003 by a group of experienced senior industry executives who have a successful track record in developing pharmaceutical products for all major global markets over the past 20 years. AGI Therape...Show all

Company (IPO / Went public)

Phone: +353 (0)1 449 3250

Fax: +353 (0)1 449 3251

Adelaide Chambers
Peter Street,

Ireland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
AGI Therapeutics $0M Feb 1, 2006
See all 31 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related AGI Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Allon Therapeutics

Vancouver, British Columbia, Canada
AcquiredAllon Therapeutics Inc. is a clinical-stage biotechnology company developing treatments for major neurodegenerative conditions. Allon has 3 Phase II human efficacy trials underway pursuing three large underserved markets: Alzheimer's disease, schizophrenia and cognitive impairment.The Company is listed on the Toronto Stock Exchange under the trading symbol "NPC" (Neuroprotection CompanyTM) and based in Vancouver.Login to see details

ARYX Therapeutics

Fremont, California, United States
IPO / Went publicARYx Therapeutics is a privately-held pharmaceutical research and development company focused on addressing safety concerns in well-established and commercially successful existing therapies through application of its proprietary ARYx RetroMetabolic (ARM) drug design. ARYx improves today's drugs, making proven therapies safer. ARYx currently has three products in clinical trials. For more information, please see the company's web site at www.aryx.com.Login to see details
See all 31 competitors